2. Irwin MF, Arthur ZE. Fitzpatrick's dermatology 6th ed. New York: Mcgrawhill. 672-688.
3. Del Rosso JQ. Retinoic acid receptors and topical acne therapy. Cutis 2002;70:127-129.
4. Wolf JE. An update of recent clinical trials examining adapalene and acne. J Eur Acad Dermatol Venereol 2001;15:Suppl 3. S23-S29.
5. Kakita L. Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris. J Am Acad Dermatol 2000;43:S51-S54.
6. Menter A. Pharmacokinetics and safety of tazarotene. J Am Acad Dermatol 2000;43:S31-S35.
7. Millikan LE. Adapalene: an update on newer comparative studies between the various retinoids. Int J Dermatol 2000;39:784-788.
8. Leyden JJ. Current issues in antimicrobial therapy for the treatment of acne. J Eur Acad Dermatol Venereol 2001;15:Suppl 3. S51-S55.
9. Russell JJ. Topical therapy for acne. Am Family Physician 2000;61:357-366.
10. Berson DS, Shalita AR. The treatment of acne: the role of combination therapies. J Am Acad Dermatol 1995;32:S31-S41.
11. Webster G. Combination azelaic acid therapy for acne vulgaris. J Am Acad Dermatol 2000;43:S47-S50.
12. Plewig G, Kligman AM. Acne and rosacea 2000;3rd ed. Berlin: Springer-Verlag. 649-680.
13. Cunliffe WJ, van de Kerkhof PC, Caputo R, Cavicchini S, Cooper A, Shaita A, et al. Roaccutane treatment guidelines: Results of an international survey. Dermatology 1997;194:351-357.
14. Wysowski DK, Swann J, Vega A. Use of isotretinoin (Accutane) in the united states: Rapid increase from 1992 through 2000. J Am Acad Dermatol 2002;46:505-509.
15. Goodman GJ. Management of post-acne scarring. What are the options for treatment? Am J Clin Dermatol 2000;1:3-17.
16. Jacob CI, Dover JS, Kaminer MS. Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol 2001;45:109-117.
17. Sawcer D, Lee HR, Lowe NJ. Lasers and adjunctive treatments for facial scars: a review. J Cutan Laser Ther 1999;1:77-85.
18. Victor ER. Optical treatments for acne. Dermatologic therapy 2005;18:253-266.